Funder
Cancer League of Colorado
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Cancer Institute
American Association of Immunologists
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research
American Cancer Society
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference58 articles.
1. Garrido, F., Aptsiauri, N., Doorduijn, E. M., Lora, A. M. G. & van Hall, T. The urgent need to recover MHC class I in cancers for effective immunotherapy. Curr. Opin. Immunol. 39, 44–51 (2016).
2. Haworth, K. B. et al. Going back to class I: MHC and immunotherapies for childhood cancer. Pediatr. Blood Cancer 62, 571–576 (2015).
3. Wang, X. et al. Histone deacetylase inhibition sensitizes PD1 blockade-resistant B-cell lymphomas. Cancer Immunol. Res. 7, 1318–1331 (2019).
4. Rosenwald, A. et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937–1947 (2002).
5. Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48–61 (2015).
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献